407582-47-2 Usage
Description
67M-2 is a derivative compound of Febuxostat 67M-1, which is an inhibitor of xanthine oxidase. It is primarily used to reduce uric acid production in the body and is also utilized to decrease the risk of gout or kidney stone formation.
Uses
Used in Pharmaceutical Industry:
67M-2 is used as an inhibitor of xanthine oxidase for reducing uric acid production in the body. This application is particularly beneficial for individuals suffering from conditions characterized by high uric acid levels, such as gout or kidney stones.
Used in Gout Treatment:
67M-2 is used as an anti-gout agent for reducing the risk of gout attacks. By lowering uric acid levels, it helps prevent the formation of urate crystals in the joints, which are responsible for the painful inflammation associated with gout.
Used in Kidney Stone Prevention:
67M-2 is used as a preventive measure for kidney stone formation. By reducing uric acid production, it minimizes the likelihood of uric acid stones developing in the kidneys, which can cause severe pain and potential damage to the urinary system.
Check Digit Verification of cas no
The CAS Registry Mumber 407582-47-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,5,8 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 407582-47:
(8*4)+(7*0)+(6*7)+(5*5)+(4*8)+(3*2)+(2*4)+(1*7)=152
152 % 10 = 2
So 407582-47-2 is a valid CAS Registry Number.
407582-47-2Relevant articles and documents
Synthesis of the major metabolites of febuxostat
Li, Xiao Long,Qiu, Rui,Wan, Wei Li,Cheng, Xu,Hai, Li,Wu, Yong
, p. 217 - 221 (2015/06/23)
Total synthesis of three Febuxostat metabolites, named 67M-1, 67M-2, and 67M-4,is described in this article. Through condensation of the key intermediate compound A with different side chains, and then oxidation and hydrolysis, we obtained three target compounds with an overall yield of 19.5%-28.0%.
